Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


LCT Appoints Scientific Advisors

Living Cell Technologies Limited

CAN: 104 028 042




LCT Appoints Scientific Advisors

23 September 2014 – Sydney, Australia & Auckland, New Zealand – Living Cell Technologies Limited (LCT) has appointed three high-level scientific advisors to review and support its work as NTCELL progresses towards commercialisation. The appointments are Professors Anne Young from Harvard, Roger Barker from Cambridge and Richard Faull from Auckland. All are internationally recognised experts on the discovery of new treatments for neurodegenerative diseases.

Professor Anne B Young, MD PhD, Distinguished Julieanne Dorn Professor of Neurology, Harvard Medical School, Boston, United States, has over 40 years’ experience studying functional neuroanatomy. Her current research focuses on studies of new therapeutic strategies for Parkinson’s and Huntington’s diseases.

Professor Roger Barker, MD PhD FRCP, Professor of Clinical Neurosciences and Deputy Director, John van Geest Centre for Brain Repair, University of Cambridge, United Kingdom, has extensive experience in evaluating and developing new therapies for Parkinson’s and Huntington’s diseases including cell therapies. His studies focus on disease heterogeneity using cognitive testing, functional imaging and genetic biomarkers.

Professor Richard Faull, ONZM MBChB PhD DSc FRSNZ, Distinguished Professor of Anatomy and Director, Centre for Brain Research, University of Auckland School of Medicine, has over 40 years’ research experience in anatomical studies of human brain neuronal growth. He directs the Centre for Brain Research which carries out research and development programs targeting neurodegenerative diseases such as Parkinson’s, Huntington’s, motor neuron and Alzheimer’s diseases.

Dr Ken Taylor, LCT chief executive says that input from these three internationally recognised experts will certainly add huge value.

“Their oversight and expertise will enhance LCT’s ability to develop and market NTCELL® therapy for Parkinson’s patients failing current therapy. Their expertise will also prove invaluable as we investigate the potential of our patented cell therapy for other neurodegenerative disorders,” said Dr Taylor.

- Ends -

© Scoop Media

Business Headlines | Sci-Tech Headlines


Mycoplasma Bovis: More Properties Positive

One of the latest infected properties is in the Hastings district, the other three are within a farming enterprise in Winton. The suspect property is near Ashburton. More>>


Manawatū Gorge Alternative: More Work Needed To Choose Route

“We are currently working closely and in partnership with local councils and other stakeholders to make the right long-term decision. It’s vital we have strong support on the new route as it will represent a very significant long-term investment and it will need to serve the region and the country for decades to come.” More>>


RBNZ: Super Fund Chief To Be New Reserve Bank Governor

Adrian Orr has been appointed as Reserve Bank Governor effective from 27 March 2018, Finance Minister Grant Robertson says. More>>


ScoopPro: Helping PR Professionals Get More Out Of Scoop has been a fixture of New Zealand’s news and Public Relations infrastructure for over 18 years. However, without the financial assistance of those using Scoop in a professional context in key sectors such as Public Relations and media, Scoop will not be able to continue this service... More>>

Insurance: 2017 Worst Year On Record For Weather-Related Losses

The Insurance Council of New Zealand (ICNZ) announced today that 2017 has been the most expensive year on record for weather-related losses, with a total insured-losses value of more than $242 million. More>>